Per Fransson

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Anders Widmark, Olbjørn Klepp, Arne Solberg et al. · The Lancet · 2008 · 863 citations · Full text

Endocrine Oncology, Urology, Radiation Medicine +8

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 840 citations

Surgical Oncology, Radiation Therapy, Medicine +8

Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

Mieke Van Hemelrijck, A. Wigertz, Fredrik Sandin et al. · International Journal of Epidemiology · 2012 · 242 citations · Full text

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson et al. · The Lancet Oncology · 2021 · 151 citations

Radiation Medicine, Radiation Therapy, Medicine +8

Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population

Anders Widmark, Per Fransson, Björn Tavelin · Cancer · 1994 · 139 citations